The success of Viagra initially drove a surge for major pharmaceutical companies, but recent changes present a murky picture for shareholders. Generic alternatives are eating into profits, and continued patent https://jasongxbx568810.blogunteer.com/39894912/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment